Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-19T01:25:05.210Z Has data issue: false hasContentIssue false
  • English
  • Français

La nefazodona puede inhibir el metabolismo de la carbamacepina: tres informes clínicos

Published online by Cambridge University Press:  12 May 2020

L. Roth  and
G. Bertschy
L. Roth
Affiliation:
Clínica de Psiquiatría Adulta, Belle-ldée, 2 ch. du Petit Bel-Air, 1225Chéne-Bourg, Suiza
G. Bertschy
Affiliation:
Clínica de Psiquiatría Adulta, Belle-ldée, 2 ch. du Petit Bel-Air, 1225Chéne-Bourg, Suiza
Get access

Abstract

An abstract is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Comunicación Breve
Information
European Psychiatry (Ed. Española) , Volume 9 , Issue 1 , February 2002 , pp. 63 - 65
Copyright
Copyright © European Psychiatric Association 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Bibliografía

Ashton, AKWolin, RE.Nefazodone-induced carbamaze-pine toxicity fletter], Am J Psychiatry 1996;15:733.Google Scholar
Greene, DSBarbhaiya, RH.Clinical pharmacokinetics of nefazodone. Clin Pharmacokinet 1997;3:260–75.CrossRefGoogle Scholar
Greene, DSSalazar, DEDokens, RCKroboth, PBarbhaiya, RH.Coadministration of nefazodone and benzodiazepi-nes: III. A pharmacokinetic interaction study with alpra-zolam. J Clin Psychopharmacol 1995;1:399–408.CrossRefGoogle Scholar
Kharasch, EDHankins, DCJubert, CThummel, KETaraday, KJ.Lack of single-dose disulfiram effects on cytochrome P-450 2C9, 2C19, 2D6, and 3A4 activities: evidence for specificity toward P-450 2E1. Drug Metab Dispos 1999;2:717–23.Google Scholar
Kroboth, PDFolan, MMLush, RMChaikin, PCShukla, UABarbhaiya, Ret al.Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment. J Clin Psychopharmacol 1995;1:306–19.CrossRefGoogle Scholar
Laroudie, CSalazar, DECosson, JPCheuvart, BIstin, BGirault, Jet al.Carbamazepine-nefazodone interaction in healthy subjects. J Clin Psychopharmacol 2000;2:46–53.CrossRefGoogle Scholar
Madan, AParkinson, AFaiman, MD.Identification of the human and rat P450 enzymes responsible for the sulfo-xidation of S-methyl N, N-diethylthiolcarbamate (DETC-ME). The terminal step in the bioactivation of disulfiram. Drug Metab Dispos 1995;2:1153–62.Google Scholar
Robinson, DSRoberts, DLSmith, JMStringfellow, JCKaplita, SBSeminara, JAet al.The safety of nefazodone. J Clin Psychiatry 1996;5(Suppl2):31–8.Google Scholar
Spina, EPisani, EPerucca, E.Clinically significant pharmacokinetic drug interactions with carbamazepine. An update. Clin Pharmacokinet 1996;3:198–214.CrossRefGoogle Scholar